January 26, 2007
Dade Behring Inc has signed a license agreement with Radboud University Nijmegen Medical Centre (RUNMC), giving Dade Behring the exclusive rights for a new coagulation test called the Nijmegen Hemostasis Assay (NHA).
The researchers at RUNMC anticipate that the assay will be accepted for testing a broad range of coagulation disorders. A research agreement was also signed giving the company the rights to results from future NHA research and development performed by RUNMC.
Researchers believe the NHA is important because it could provide insight into the whole blood-clotting process simultaneously in one test.
